Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazanin Falconer

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|January 17, 2018
Systematic review of predictive risk models for adverse drug events in hospitalized patientsNazanin Falconer, Michael Barras, Neil Cottrell
Research in Social & Administrative Pharmacy : RSAP|November 24, 2018
How hospital pharmacists prioritise patients at high-risk for medication harmNazanin Falconer, Michael Barras, Neil Cottrell
The International Journal of Pharmacy Practice|March 17, 2021
The pharmacist informatician: providing an innovative model of care during the COVID-19 crisisNazanin Falconer, Corey Monaghan, Centaine L Snoswell
European Journal of Clinical Pharmacology|October 13, 2018
Defining and classifying terminology for medication harm: a call for consensusNazanin Falconer, Michael Barras, Jennifer Martin, et al.
Journal of Medical Systems|August 22, 2024
Evaluating EHR-Integrated Digital Technologies for Medication-Related Outcomes and Health Equity in Hospitalised Adults: A Scoping ReviewSreyon Murthi, Nataly Martini, Nazanin Falconer, et al.
The American Journal of Emergency Medicine|November 8, 2023
Impact of pharmacists during in-hospital resuscitation or medical emergency response events: A systematic reviewElizabeth M Currey, Nazanin Falconer, Katherine Z Isoardi, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 1, 2014
Development of an electronic patient prioritization tool for clinical pharmacist interventionsNazanin Falconer, Sanjoy Nand, Doreen Liow, et al.
Australian Prescriber|March 5, 2025
The role of triple antithrombotic therapy in patients with atrial fibrillation and coronary stent insertionKate Ziser, Saqib Rahman, Reham Soro, et al.
Expert Review of Clinical Pharmacology|November 13, 2024
A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital settingBenjamin Deutscher, Keshia De Guzman, Adam La Caze, et al.
European Journal of Clinical Pharmacology|January 18, 2022
Evaluation of two European risk models for predicting medication harm in an Australian patient cohortNazanin Falconer, Michael Barras, Ahmad Abdel-Hafiz, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|January 17, 2018
Systematic review of predictive risk models for adverse drug events in hospitalized patientsNazanin Falconer, Michael Barras, Neil Cottrell
Research in Social & Administrative Pharmacy : RSAP|November 24, 2018
How hospital pharmacists prioritise patients at high-risk for medication harmNazanin Falconer, Michael Barras, Neil Cottrell
The International Journal of Pharmacy Practice|March 17, 2021
The pharmacist informatician: providing an innovative model of care during the COVID-19 crisisNazanin Falconer, Corey Monaghan, Centaine L Snoswell
European Journal of Clinical Pharmacology|October 13, 2018
Defining and classifying terminology for medication harm: a call for consensusNazanin Falconer, Michael Barras, Jennifer Martin, et al.
Journal of Medical Systems|August 22, 2024
Evaluating EHR-Integrated Digital Technologies for Medication-Related Outcomes and Health Equity in Hospitalised Adults: A Scoping ReviewSreyon Murthi, Nataly Martini, Nazanin Falconer, et al.
The American Journal of Emergency Medicine|November 8, 2023
Impact of pharmacists during in-hospital resuscitation or medical emergency response events: A systematic reviewElizabeth M Currey, Nazanin Falconer, Katherine Z Isoardi, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 1, 2014
Development of an electronic patient prioritization tool for clinical pharmacist interventionsNazanin Falconer, Sanjoy Nand, Doreen Liow, et al.
Australian Prescriber|March 5, 2025
The role of triple antithrombotic therapy in patients with atrial fibrillation and coronary stent insertionKate Ziser, Saqib Rahman, Reham Soro, et al.
Expert Review of Clinical Pharmacology|November 13, 2024
A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital settingBenjamin Deutscher, Keshia De Guzman, Adam La Caze, et al.
European Journal of Clinical Pharmacology|January 18, 2022
Evaluation of two European risk models for predicting medication harm in an Australian patient cohortNazanin Falconer, Michael Barras, Ahmad Abdel-Hafiz, et al.
Pageof 4